Intravenous immune globulin has been used in the treatment of primary and secondary antibody deficiencies for more than 25 years. It is a safe preparation with no long-term side effects. Intravenous ...
In November 2000, a questionnaire was sent to 410 centers listed as participating in the International Bone Marrow Transplant Registry. Information requested on the questionnaire included the location ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback